Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/317
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing
Description: Subject matter which contains an additional ring.

Sub-classes under this class:

Class Number	Class Name	Patents
514/330	C=x bonded directly to the piperidine ring (x is chalcogen)	582
514/327	Chalcogen bonded directly to ring carbon of the piperidine ring	506
514/329	Nitrogen attached directly to the piperidine ring by nonionic bonding	321
514/331	Nitrogen attached indirectly to the piperidine ring by nonionic bonding	735
514/326	The additional ring is a hetero ring	1,671
514/318	The additional ring is a six-membered hetero ring consisting of one nitrogen and five carbon atoms	1,302
514/319	The additional ring is one of the cyclos in a polycyclo ring system	587

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Patent Number	Title Of Patent	Date Issued
6221898	Amidino derivatives and their use as thrombin inhibitors	Apr. 24, 2001
6221883	Method of dopamine inhibition using l-threo-methylphenidate	Apr. 24, 2001
6218404	Subtype-selective NMDA receptor ligands and the use thereof	Apr. 17, 2001
6211172	Methods and compositions for controlling biofouling using sulfonamides	Apr. 3, 2001
6207682	Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1propyl)-3-pipe ridinecarboxylic acid	Mar. 27, 2001
6207681	Methods and compositions for treating urinary incontinence using enantiomerically enriched (R)-trihexyphenidyl	Mar. 27, 2001
6194435	Lactams as selective factor Xa inhibitors	Feb. 27, 2001
6194431	Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors	Feb. 27, 2001
6187791	Method of providing an antihistaminic effect in a hepatically impaired patient	Feb. 13, 2001
6180648	Analogs of cocaine	Jan. 30, 2001
6174879	Aminocyclohexylesters and uses thereof	Jan. 16, 2001
6174923	Use of ethynyl alanine amino diol compounds for treatment of renin-mediated disorders	Jan. 16, 2001
6174899	Orally administered analgesic composition comprising myfadol	Jan. 16, 2001
6174900	Substituted piperidine derivative for treating urinary disturbance	Jan. 16, 2001
6159988	Arylcycloalkyl derivatives, their production and their use	Dec. 12, 2000
6153624	Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders	Nov. 28, 2000
6153623	Cisapride extended release	Nov. 28, 2000
6153611	Piperazinyl-cyclohexanes and cyclohexenes	Nov. 28, 2000
6143747	Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors	Nov. 7, 2000
6140344	4-aroylpiperidine derivatives-CCR-3 receptor antagonists	Oct. 31, 2000
6136802	Fungicidal mixtures	Oct. 24, 2000
6136824	1-piperidinyl-propan-2-derivatives and their use as therapeutic agents	Oct. 24, 2000
6136794	Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist	Oct. 24, 2000
6136803	Antidepressants	Oct. 24, 2000
6127385	Method of treating depression using l-threo-methylphenidate	Oct. 3, 2000
6124318	Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them	Sep. 26, 2000
6124317	2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists	Sep. 26, 2000
6124314	Osteoporosis compounds	Sep. 26, 2000
6124361	Bicyclo[3.1.0]hexanes and related compounds	Sep. 26, 2000
6121290	Use of GABA uptake inhibitors as anti-tussive agents	Sep. 19, 2000
6113942	Pharmaceutical composition for piperidinoalkanol compounds	Sep. 5, 2000
6110937	Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain	Aug. 29, 2000
6110936	3-phenyl-furan-(5H)-2-one and dihydrofuran-2-one derivatives as antibacterial agents	Aug. 29, 2000
6100266	Hydroxamic and carboxylic acid derivatives	Aug. 8, 2000
6096760	Solid .alpha.-phenyl-2-piperidine acetate free base, its preparation and use in medicine	Aug. 1, 2000
6096761	Esters of 3-hydroxy-piperidinemethanol derivatives	Aug. 1, 2000
6090824	Therapeutic neurokinin receptor antagonist compounds	Jul. 18, 2000
6087376	Use of lobeline compounds in the treatment of central nervous system diseases and pathologies	Jul. 11, 2000
6083943	Substituted azaheterocyclecarboxylic acid	Jul. 4, 2000
6066643	Potentiation of pharmaceuticals	May. 23, 2000
6066652	Method for treating diseases of the inner ear using adamantane derivatives	May. 23, 2000
6063793	Esters of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidi nemethanol	May. 16, 2000
6048876	Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor	Apr. 11, 2000
6043251	Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyr idine for preparing drugs for treating amyotrophic lateral sclerosis	Mar. 28, 2000
6040317	Sulfonamide fibrinogen receptor antagonists	Mar. 21, 2000
6037352	Muscarinic antagonists	Mar. 14, 2000
6037353	Method of providing an antihistaminic effect in a hepatically impaired patient	Mar. 14, 2000
6034102	Atherosclerosis treatment	Mar. 7, 2000
6028083	Esters of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol	Feb. 22, 2000
6022878	Inhibitors of rotamase enzyme activity	Feb. 8, 2000